COVID-19 Accounts For Most Of 2020’s Pharma Pipeline Growth
Novartis Still Dominates Pipeline But Roche Catches Up
The impact of the coronavirus pandemic on the size of the pharma R&D pipeline in 2020 could be felt in a number of ways.
The impact of the coronavirus pandemic on the size of the pharma R&D pipeline in 2020 could be felt in a number of ways.